SCHEMBL4606554

SCHEMBL4606554

NC1CCCC1c1ccc(-c2ccccc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 12/20 0.66
MAOB P27338 9/20 0.66
MAOA P21397 7/20 0.47
CYP2C19 P33261 4/20 0.47
CYP2B6 P20813 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C9 P11712 2/20 0.47
LMNA P02545 2/20 0.47
SLC6A2 P23975 2/20 0.47
TAAR1 Q96RJ0 2/20 0.47
CYP3A4 P08684 1/20 0.47
HTR1A P08908 1/20 0.47
ADRA2A P08913 1/20 0.47
CYP2A6 P11509 1/20 0.47
HTR2C P28335 1/20 0.47
ADRA1A P35348 1/20 0.47
DRD3 P35462 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KCNH2 Q12809 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cypenamine SCHEMBL13813781 0.88 KDM1A (0.60) KDM1AMAOBMAOACYP2C19CYP2B6
Cypenamine SCHEMBL293404 0.88 KDM1A (0.60) KDM1AMAOBMAOACYP2C19CYP2B6
Cypenamine SCHEMBL293405 0.88 KDM1A (0.60) KDM1AMAOBMAOACYP2C19CYP2B6
Cypenamine SCHEMBL12261999 0.88 KDM1A (0.60) KDM1AMAOBMAOACYP2C19CYP2B6
Cypenamine SCHEMBL4418958 0.88 KDM1A (0.60) KDM1AMAOBMAOACYP2C19CYP2B6
Cypenamine SCHEMBL295252 0.88 KDM1A (0.60) KDM1AMAOBMAOACYP2C19CYP2B6
Cypenamine SCHEMBL7307497 0.86 MAOB (0.61) KDM1AMAOBMAOACYP2C19CYP2B6
Cypenamine SCHEMBL119769 0.86 MAOB (0.61) KDM1AMAOBMAOACYP2C19CYP2B6
Cypenamine SCHEMBL7316865 0.86 MAOB (0.61) KDM1AMAOBMAOACYP2C19CYP2B6
SCHEMBL12261925 0.84 MAOB (0.60) KDM1AMAOBMAOACYP2C19CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP claimed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US claimed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP claimed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO claimed
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP disclosed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US disclosed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP disclosed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO disclosed